Acute Leukemias - Republican Scientific Medical Library
Acute Leukemias - Republican Scientific Medical Library
Acute Leukemias - Republican Scientific Medical Library
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
122 Chapter 8 · Diagnosis of <strong>Acute</strong> Lymphoblastic Leukemia<br />
Terminal deoxynucleotidyltransferase (TdT) expression<br />
along with CD19+ or cyCD79a and surface or cytoplasmic<br />
CD22+ are diagnostic for early precursor B-cell<br />
involvement, irrespective of CD13 and CD33 expression.<br />
The expression of CD10 (common ALL antigen,<br />
CALLA) in addition to the above markers is diagnostic<br />
for more mature (intermediate) precursor ALL.<br />
Although CD19 protein expression is diagnostic for Bcell<br />
lineage, it is detected in 80% of acute myeloid leukemia<br />
(AML) cases that carry the t(8;21) chromosomal<br />
abnormality [46]; however, these cases are MPO positive<br />
and easily distinguished from ALL. CD20 is expressed<br />
in approximately 55% of patients with precursor<br />
B-cell ALL and more frequently in Burkitt leukemia patients.<br />
In most but not all cases, precursor B-cell cells<br />
are surface IgM-negative. Blast cells that lack TdT expression<br />
are classified as Burkitt (L3) if they show L3type<br />
morphology (vacuolated, deeply basophilic cytoplasm);<br />
otherwise, they should be classified as “Burkitt-like.”<br />
Most importantly, these cells must show blast<br />
morphology (Fig. 8.1).<br />
The diagnosis of precursor T-cell ALL is based on<br />
lack of expression of B-cell markers and expression of<br />
surface CD3 (sCD3) or cytoplasmic CD3 (cyCD3) in<br />
MPO-negative/NSE-negative blasts. However, approximately<br />
10% of precursor T-cell ALL cases are TdT negative<br />
[25] and many coexpress CD4, CD8, and CD2. Lack<br />
of CD1a expression indicates early-stage differentiation;<br />
these T-cell ALL cases appear to be especially aggressive<br />
[71].<br />
8.4 Atypical <strong>Acute</strong> Lymphoblastic Leukemia<br />
8.4.1 Burkitt-Like (Atypical Burkitt) ALL<br />
Rare cases of ALL show blasts with only mature B-cell<br />
markers (TdT–, CD19+, and surface IgM+) that are<br />
morphologically similar to the L2 rather than L3 cell<br />
type (lack deep blue cytoplasm with vacuoles). These<br />
cases are classified as Burkitt-like and are treated as<br />
Burkitt leukemia [24, 25].<br />
8.4.2 ALL with Eosinophilia<br />
Some cases of ALL demonstrate significant eosinophilia,<br />
which appears to be stimulated by the secretion of<br />
IL-5 and IL-3. The eosinophils have normal morphology<br />
and are reactive, not leukemic. In some of these pa-<br />
tients, the IL-3 gene on chromosome 5q31 is translocated<br />
to the IgH gene locus on chromosome 14 (translocation<br />
t(5;14) (q31;q32) [9, 71, 83]. Rarely, patients may present<br />
with eosinophilia without evidence of ALL, raising the<br />
question of hypereosinophilic syndrome, which converts<br />
to ALL within weeks to months. The eosinophilia<br />
disappears with remission and may come back as an<br />
early sign of relapse [9, 71, 83].<br />
8.4.3 Aplastic and Hypoplastic ALL<br />
Rarely, young patients with ALL may present with hypoplastic<br />
or aplastic bone marrow. In the early stage,<br />
leukemic blasts may not be conspicuous and overt leukemia<br />
may manifest within weeks to months after marrow<br />
recovery. This manifestation is frequently interpreted<br />
as myelodysplastic syndrome or aplastic anemia,<br />
but the lack of dysplastic changes should help rule out<br />
myelodysplastic syndrome. This phenomenon may be<br />
due to an unusual immune response attempting to suppress<br />
the leukemic hematopoietic cells, which coincidentally<br />
suppresses normal hematopoietic cells. The<br />
other possibility is that the leukemic cells produce inhibiting<br />
factors that suppress normal hematopoiesis<br />
[71, 55].<br />
8.4.4 Granular ALL<br />
Rare cases of ALL show significant numbers of blasts<br />
with large (0.25-micron) basophilic granules. These<br />
granules are believed to be either abnormal mitochondria<br />
or cytoplasmic organelles, but their clinical significance<br />
is not known. Although the granules are MPO<br />
negative, they are more common in ALL cases that coexpress<br />
myeloid markers [37, 42, 71]. The blasts should<br />
not be confused with those of acute basophilic leukemia,<br />
which is more frequently seen in patients with acutephase<br />
CML.<br />
8.4.5 Hand Mirror ALL<br />
Blasts in some cases of leukemia show uropod (handle)<br />
morphology with elongated cytoplasm, which may represent<br />
an attachment or endocytotic process. This morphology<br />
can be seen in reactive lymphoid and monocytoid<br />
cells as well as blasts. Once thought to be specific<br />
for ALL or mixed-lineage leukemia, this morphology<br />
can also be seen in AML [81].